BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh P, Ananthakrishnan A, Ahuja V. Pivot to Asia: inflammatory bowel disease burden. Intest Res. 2017;15:138-141. [PMID: 28239326 DOI: 10.5217/ir.2017.15.1.138] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Tadin Hadjina I, Zivkovic PM, Matetic A, Rusic D, Vilovic M, Bajo D, Puljiz Z, Tonkic A, Bozic J. Impaired neurocognitive and psychomotor performance in patients with inflammatory bowel disease. Sci Rep 2019;9:13740. [PMID: 31551482 DOI: 10.1038/s41598-019-50192-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
2 Kedia S, Das P, Madhusudhan KS, Dattagupta S, Sharma R, Sahni P, Makharia G, Ahuja V. Differentiating Crohn’s disease from intestinal tuberculosis. World J Gastroenterol 2019; 25(4): 418-432 [PMID: 30700939 DOI: 10.3748/wjg.v25.i4.418] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 20] [Article Influence: 10.7] [Reference Citation Analysis]
3 Sood A, Kaur K, Mahajan R, Midha V, Singh A, Sharma S, Puri AS, Goswami B, Desai D, Pai CG, Peddi K, Philip M, Kochhar R, Nijhawan S, Bhatia S, Rao NS. Colitis and Crohn's Foundation (India): a first nationwide inflammatory bowel disease registry. Intest Res 2021;19:206-16. [PMID: 32646197 DOI: 10.5217/ir.2019.09169] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Kamat N, Kedia S, Ghoshal UC, Nehra A, Makharia G, Sood A, Midha V, Gupta V, Choudhuri G, Ahuja V. Effectiveness and safety of adalimumab biosimilar in inflammatory bowel disease: A multicenter study. Indian J Gastroenterol. 2019;38:44-54. [PMID: 30645725 DOI: 10.1007/s12664-018-0922-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 5.3] [Reference Citation Analysis]
5 Kedia S, Ahuja V. Is the emergence of inflammatory bowel disease a prime example of "the third epidemiological transition?". Indian J Gastroenterol. 2018;37:183-185. [PMID: 29948992 DOI: 10.1007/s12664-018-0852-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
6 Jung YS, Han M, Kim WH, Park S, Cheon JH. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study. Dig Dis Sci. 2017;62:2102-2112. [PMID: 28593437 DOI: 10.1007/s10620-017-4640-9] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 6.8] [Reference Citation Analysis]
7 Ohya S, Matsui M, Kajikuri J, Endo K, Kito H. Increased Interleukin-10 Expression by the Inhibition of Ca2+-Activated K+ Channel KCa3.1 in CD4+CD25+ Regulatory T Cells in the Recovery Phase in an Inflammatory Bowel Disease Mouse Model. J Pharmacol Exp Ther 2021;377:75-85. [PMID: 33504590 DOI: 10.1124/jpet.120.000395] [Reference Citation Analysis]
8 Ananthakrishnan AN, Kaplan GG, Ng SC. Changing Global Epidemiology of Inflammatory Bowel Diseases: Sustaining Health Care Delivery Into the 21st Century. Clinical Gastroenterology and Hepatology 2020;18:1252-60. [DOI: 10.1016/j.cgh.2020.01.028] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 19.0] [Reference Citation Analysis]
9 Gobert AP, Latour YL, Asim M, Barry DP, Allaman MM, Finley JL, Smith TM, McNamara KM, Singh K, Sierra JC, Delgado AG, Luis PB, Schneider C, Washington MK, Piazuelo MB, Zhao S, Coburn LA, Wilson KT. Protective Role of Spermidine in Colitis and Colon Carcinogenesis. Gastroenterology 2021:S0016-5085(21)03727-6. [PMID: 34767785 DOI: 10.1053/j.gastro.2021.11.005] [Reference Citation Analysis]
10 Tambuwala MM, Khan MN, Thompson P, McCarron PA. Albumin nano-encapsulation of caffeic acid phenethyl ester and piceatannol potentiated its ability to modulate HIF and NF-kB pathways and improves therapeutic outcome in experimental colitis. Drug Deliv Transl Res 2019;9:14-24. [PMID: 30430451 DOI: 10.1007/s13346-018-00597-9] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
11 Kedia S, Madhusudhan KS, Sharma R, Bopanna S, Yadav DP, Goyal S, Jain S, Das P, Dattagupta S, Makharia G, Ahuja V. Combination of increased visceral fat and long segment involvement: Development and validation of an updated imaging marker for differentiating Crohn's disease from intestinal tuberculosis. J Gastroenterol Hepatol. 2018;33:1234-1241. [PMID: 29205485 DOI: 10.1111/jgh.14065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
12 Arora U, Kedia S, Garg P, Bopanna S, Jain S, Yadav DP, Goyal S, Gupta V, Sahni P, Pal S, Dash NR, Madhusudhan KS, Sharma R, Makharia G, Ahuja V. Colonic Crohn's Disease Is Associated with Less Aggressive Disease Course Than Ileal or Ileocolonic Disease. Dig Dis Sci. 2018;63:1592-1599. [PMID: 29611078 DOI: 10.1007/s10620-018-5041-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Tomar SK, Kedia S, Upadhyay AD, Bopanna S, Yadav DP, Goyal S, Jain S, Makharia G, Ahuja V, Singh N. Impact of dietary beliefs and practices on patients with inflammatory bowel disease: An observational study from India. JGH Open. 2017;1:15-21. [PMID: 30483527 DOI: 10.1002/jgh3.12002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
14 Kedia S, Ahuja V. Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East. Inflamm Intest Dis. 2017;2:102-115. [PMID: 30018961 DOI: 10.1159/000465522] [Cited by in Crossref: 43] [Cited by in F6Publishing: 37] [Article Influence: 8.6] [Reference Citation Analysis]
15 Juyal G, Sood A, Midha V, Thelma BK. Genetics of ulcerative colitis: putting into perspective the incremental gains from Indian studies. J Genet 2018;97:1493-507. [DOI: 10.1007/s12041-018-1015-8] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
16 Sood A, Ahuja V, Midha V, Sinha SK, Pai CG, Kedia S, Mehta V, Bopanna S, Abraham P, Banerjee R, Bhatia S, Chakravartty K, Dadhich S, Desai D, Dwivedi M, Goswami B, Kaur K, Khosla R, Kumar A, Mahajan R, Misra SP, Peddi K, Singh SP, Singh A. Colitis and Crohn's Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease. Intest Res 2020;18:355-78. [PMID: 32646198 DOI: 10.5217/ir.2019.09176] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Tomar SK, Kedia S, Singh N, Upadhyay AD, Kamat N, Bopanna S, Yadav DP, Goyal S, Jain S, Makharia G, Ahuja V. Higher education, professional occupation, and upper socioeconomic status are associated with lower adherence to medications in patients with inflammatory bowel disease. JGH Open 2019;3:302-9. [PMID: 31406923 DOI: 10.1002/jgh3.12160] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
18 Kochar B. Inflammatory Bowel Diseases in South Asian Patients: Underappreciated and Understudied. Inflamm Bowel Dis 2020;26:1943-4. [PMID: 32115646 DOI: 10.1093/ibd/izaa040] [Reference Citation Analysis]
19 Kedia S, Ahuja V. Intestinal tuberculosis or Crohn's disease: Illusion or delusion or allusion. JGH Open 2021;5:177-9. [PMID: 33553652 DOI: 10.1002/jgh3.12495] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Gobert AP, Al-Greene NT, Singh K, Coburn LA, Sierra JC, Verriere TG, Luis PB, Schneider C, Asim M, Allaman MM, Barry DP, Cleveland JL, Destefano Shields CE, Casero RA Jr, Washington MK, Piazuelo MB, Wilson KT. Distinct Immunomodulatory Effects of Spermine Oxidase in Colitis Induced by Epithelial Injury or Infection. Front Immunol 2018;9:1242. [PMID: 29922289 DOI: 10.3389/fimmu.2018.01242] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
21 Agarwal A, Kedia S, Jain S, Gupta V, Bopanna S, Yadav DP, Goyal S, Mouli VP, Dhingra R, Makharia G, Ahuja V. High risk of tuberculosis during infliximab therapy despite tuberculosis screening in inflammatory bowel disease patients in India. Intest Res 2018;16:588-98. [PMID: 30301331 DOI: 10.5217/ir.2018.00023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
22 Imawana RA, Smith DR, Goodson ML. The relationship between inflammatory bowel disease and Helicobacter pylori across East Asian, European and Mediterranean countries: a meta-analysis. Ann Gastroenterol 2020;33:485-94. [PMID: 32879595 DOI: 10.20524/aog.2020.0507] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Lee HS, Park SK, Park DI. Novel treatments for inflammatory bowel disease. Korean J Intern Med 2018;33:20-7. [PMID: 29223139 DOI: 10.3904/kjim.2017.393] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
24 Jeon SR, Chai J, Kim C, Lee CH. Current Evidence for the Management of Inflammatory Bowel Diseases Using Fecal Microbiota Transplantation. Curr Infect Dis Rep 2018;20:21. [PMID: 29804272 DOI: 10.1007/s11908-018-0627-8] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
25 Kim JM, Kang JG, Kim S, Cheon JH. Deep-learning system for real-time differentiation between Crohn's disease, intestinal Behçet's disease, and intestinal tuberculosis. J Gastroenterol Hepatol 2021;36:2141-8. [PMID: 33554375 DOI: 10.1111/jgh.15433] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Snell A, Segal J, Limdi J, Banerjee R. Inflammatory bowel disease in India: challenges and opportunities. Frontline Gastroenterol 2021;12:390-6. [DOI: 10.1136/flgastro-2020-101500] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Kedia S, Limdi JK, Ahuja V. Management of inflammatory bowel disease in older persons: evolving paradigms. Intest Res 2018;16:194-208. [PMID: 29743832 DOI: 10.5217/ir.2018.16.2.194] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
28 Lee J, Im JP, Han K, Kim J, Lee HJ, Chun J, Kim JS. Changes in Direct Healthcare Costs before and after the Diagnosis of Inflammatory Bowel Disease: A Nationwide Population-Based Study. Gut Liver. 2020;14:89-99. [PMID: 31158951 DOI: 10.5009/gnl19023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
29 Hatton GB, Madla CM, Rabbie SC, Basit AW. All disease begins in the gut: Influence of gastrointestinal disorders and surgery on oral drug performance. Int J Pharm 2018;548:408-22. [PMID: 29969711 DOI: 10.1016/j.ijpharm.2018.06.054] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 7.5] [Reference Citation Analysis]
30 Jeong Y, Jeon SR, Kim HG, Moon JR, Lee TH, Jang JY, Cho JH, Park JS, Park H, Lee KH, Kim JO, Lee JS, Ko BM, Park S. The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis. Intest Res 2021;19:62-70. [PMID: 32375208 DOI: 10.5217/ir.2019.09156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
31 Park J, Cheon JH. Incidence and Prevalence of Inflammatory Bowel Disease across Asia. Yonsei Med J 2021;62:99-108. [PMID: 33527789 DOI: 10.3349/ymj.2021.62.2.99] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Yadav DP, Kedia S, Madhusudhan KS, Bopanna S, Goyal S, Jain S, Vikram NK, Sharma R, Makharia GK, Ahuja V. Body Composition in Crohn's Disease and Ulcerative Colitis: Correlation with Disease Severity and Duration.Can J Gastroenterol Hepatol. 2017;2017:1215035. [PMID: 29226115 DOI: 10.1155/2017/1215035] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
33 Singh K, Gobert AP, Coburn LA, Barry DP, Allaman M, Asim M, Luis PB, Schneider C, Milne GL, Boone HH, Shilts MH, Washington MK, Das SR, Piazuelo MB, Wilson KT. Dietary Arginine Regulates Severity of Experimental Colitis and Affects the Colonic Microbiome. Front Cell Infect Microbiol 2019;9:66. [PMID: 30972302 DOI: 10.3389/fcimb.2019.00066] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
34 Tadin Hadjina I, Zivkovic PM, Matetic A, Rusic D, Vilovic M, Bajo D, Puljiz Z, Tonkic A, Bozic J. Impaired neurocognitive and psychomotor performance in patients with inflammatory bowel disease. Sci Rep. 2019;9:13740. [PMID: 31551482 DOI: 10.1030/s41598-019-50192-2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
35 da Luz Moreira A, de Campos Lobato LF, de Lima Moreira JP, Luiz RR, Elia C, Fiocchi C, de Souza HSP. Geosocial Features and Loss of Biodiversity Underlie Variable Rates of Inflammatory Bowel Disease in a Large Developing Country: A Population-Based Study. Inflamm Bowel Dis 2022:izab346. [PMID: 35089325 DOI: 10.1093/ibd/izab346] [Reference Citation Analysis]
36 Yewale RV, Natarajan K, Ubal Dhus J, Parameswaran SA, Ramaswamy Palaniswamy K, Babu Vinish D, Somasundaram A, Ramakrishnan A, Karmegam S, Arun RS, Manmohan US, Mahadevan B, Harri Prasad B, Chandrasekar TS, Gokul BJ, Dutta A, Joseph AJ, Venkatraman J, Ganesh P, Shanmuganathan S, Alagammai PL, Ramasubramanian R, Venkatakrishnan L, Ganesan R, Chandrasekaran Arun A, Srinivas S, Kannan M, Revathy MS, Sathiyasekaran M, Sarangapani A, Rajesh N, Arulselvan V, Aravind A, Premkumar K, Kavitha S, Varadarajulu HV, Manimaran M, Basumani P, Murali A, Ramakrishna BS. Inflammatory bowel diseases in Tamil Nadu: A survey of demographics, clinical profile, and practices. JGH Open 2021;5:1306-13. [PMID: 34816017 DOI: 10.1002/jgh3.12673] [Reference Citation Analysis]
37 Copeland JK, Chao G, Vanderhout S, Acton E, Wang PW, Benchimol EI, El Sohami A, Croitoru K, Gommerman JL, Guttman DS; GEMINI Research Team. The Impact of Migration on the Gut Metagenome of South Asian Canadians. Gut Microbes 2021;13:1-29. [PMID: 33794735 DOI: 10.1080/19490976.2021.1902705] [Reference Citation Analysis]
38 Rampal R, Kedia S, Wari MN, Madhu D, Singh AK, Tiwari V, Mouli VP, Mohta S, Makharia G, Ahuja V. Prospective validation of CD4+CD25+FOXP3+ T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn's disease. Intest Res 2021;19:232-8. [PMID: 32375209 DOI: 10.5217/ir.2019.09181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
39 Ma S, Yeom J, Lim YH. Dairy Propionibacterium freudenreichii ameliorates acute colitis by stimulating MUC2 expression in intestinal goblet cell in a DSS-induced colitis rat model. Sci Rep 2020;10:5523. [PMID: 32218552 DOI: 10.1038/s41598-020-62497-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
40 Jain S, Kedia S, Bopanna S, Yadav DP, Goyal S, Sahni P, Pal S, Dash NR, Makharia G, Travis SPL, Ahuja V. Are Truelove and Witts criteria for diagnosing acute severe colitis relevant for the Indian population? A prospective study. Intest Res 2018;16:69-74. [PMID: 29422800 DOI: 10.5217/ir.2018.16.1.69] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
41 Sahu P, Vuyyuru SK, Kante B, Agarwal A, Sharma R, Das P, Panwar R, Jain S, Bopanna S, Makharia G, Kedia S, Ahuja V. Relapse rate following withdrawal of anti-TNF therapy in patients with inflammatory bowel disease: A real-life cohort from northern India. Indian J Gastroenterol 2020;39:388-97. [PMID: 32880844 DOI: 10.1007/s12664-020-01043-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
42 Pirmanesh S, Mirzaei N, Azimirad M, Yadegar A, Kao JY, Aghdaei HA, Zali MR. A report of nonexistence of the non-Helicobacter pylori Helicobacter species in Iranian patients suffering from inflammatory bowel disease. Folia Microbiol (Praha) 2021. [PMID: 34101130 DOI: 10.1007/s12223-021-00883-z] [Reference Citation Analysis]